|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2019
|
1. |
Glover, Joel; Tysnes, Ole-Bjørn; Myhr, Kjell-Morten; Bråthen, Geir; Sandvig, Ioanna; Høyer, Helle; Holmøy, Trygve; Nakken, Ola; Harbo, Hanne Flinstad. Hvor står ALS-forskningen i Norge?. VG : Verdens gang 2019 UiO UiB NTNU STHF
Untitled
|
|
2. |
Holmøy, Trygve; Fevang, Børre; Olsen, David Benee; Spigset, Olav; Bø, Lars. Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes 2019 ;Volum 12.(1) s. 1-5 UiO AHUS OUS NTNU STO UiB HAUKELAND
Untitled
|
|
3. |
Holmøy, Trygve; Fogdell-Hahn, Anna; Svenningsson, Anders. Serum sickness following rituximab therapy in multiple sclerosis. Neurology: Clinical Practice 2019 ;Volum 9.(6) s. 519-521 UiO AHUS
Untitled
|
|
4. |
Hupperts, Raymond; Smolders, Joost; Vieth, Reinhold; Holmøy, Trygve; Marhardt, Kurt; Schluep, Myriam; Killestein, Joep; Barkhof, Frederik; Beelke, Manolo; Grimaldi, Luigi M. E.. Randomized trial daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a. Neurology 2019 ;Volum 93.(20) s. E1906-E1916 AHUS UiO
Untitled
|
|
5. |
Høglund, Rune Alexander; Myro, Aija Zuleron; Zarnovicky, Svetozar; Holmøy, Trygve. En ung kvinne med krampeanfall, synsforstyrrelser og lammelser. Tidsskrift for Den norske legeforening 2019 ;Volum 139.(11) s. - UiO AHUS
Untitled
|
|
6. |
Høglund, Rune Alexander; Torsetnes, Silje Bøen; Lossius, Peter Andreas Vold; Bogen, Bjarne; Homan, E. Jane; Bremel, Robert; Holmøy, Trygve. Human cysteine cathepsins degrade immunoglobulin G in vitro in a predictable manner. International Journal of Molecular Sciences 2019 ;Volum 20:4843.(19) s. 1-19 UiO AHUS
Untitled
|
|
7. |
Larsen, Christopher Storm; Myhr, Kjell-Morten; Farbu, Elisabeth; Midgard, Rune; Nyquist, Kaja Beate; Broch, Line; Berg-Hansen, Pål; Buness, A; Holm, Kristian; Ueland, Thor; Fallang, Lars-Egil; Burum-Auensen, Espen; Hov, Johannes Espolin Roksund; Holmøy, Trygve. Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial. Multiple Sclerosis Journal, Experimental, Translational and Clinical 2019 ;Volum 5.(4) s. 1-13 UiB VV OUS NTNU UiO HAUKELAND HMR SUS SI AHUS UiT
Untitled
|
|
8. |
Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve. B cell depletion in the treatment of multiple sclerosis. Expert Opinion on Biological Therapy 2019 ;Volum 19.(3) s. 261-271 UiB HAUKELAND UiO OUS AHUS
Untitled
|
|
9. |
Nakken, Ola; Meyer, Haakon E; Stigum, Hein; Holmøy, Trygve. High BMI is associated with low ALS risk: A population-based study. Neurology 2019 ;Volum 93.(5) s. e424-e432 FHI AHUS UiO
Untitled
|
|
10. |
Smolders, Joost; Torkildsen, Øivind; Camu, William; Holmøy, Trygve. An Update on Vitamin D and Disease Activity in Multiple Sclerosis. CNS Drugs 2019 ;Volum 33.(12) s. 1187-1199 UiB HAUKELAND UiO AHUS
Untitled
|
|
11. |
Tomescu-Baciu, Alina; Johansen, Jorunn; Holmøy, Trygve; Greiff, Victor; Stensland, Maria; De Souza, Gustavo Antonio; Vartdal, Frode; Lossius, Peter Andreas Vold. Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis. Journal of Neuroimmunology 2019 ;Volum 333:576966. s. 1-7 OUS UiO AHUS
Untitled
|
|